… Differential diagnosis of a rapidly enlarging neck mass includes aggressive thyroid cancers,
such as poorly differentiated thyroid cancer (PDTC), and ATC, primary thyroid lymphoma, …

… Locally advanced thyroid cancer refers to thyroid cancer that invades important structures …
therapy has the potential to increase the R0/1 resection rate in locally advanced thyroid cancer …

… two or more systemic therapies in patients with advanced and/or metastatic thyroid cancer
were … refractory well-differentiated thyroid cancer (RR-WDTC) and three RCTs in medullary …

… is variable in patients with metastatic differentiated thyroid cancer (DTC), and therefore the
… to treat with systemic therapy. The ideal time to initiate systemic therapy remains unclear. A …

… systemic disease progression (calling for systemic therapy) helps in determining the appropriate
therapeutic … Doxorubicin is the only FDA-approved drug for systemic therapy that may …

… Therapy with MIBG in pheochromococytoma as well as targeted radiopeptide therapy in
medullary thyroid cancer … an overall systemic therapeutic approach to this promising endeavor. …

… (ATC) is a rare but very aggressive form of undifferentiated thyroid cancer. Due to its …
therapeutic targets have been identified. Systemic therapy (chemotherapy and radiation therapy) as …

… leading to thyroid cancers in recent years we have seen a rapid increase in the number of
effective targeted systemic therapies available for patients with advanced thyroid cancer; firstly …

… ) should be performed before initiating systemic therapy with multi-target kinase inhibitors
(… Consequently, local therapies, including surgery, are preferred to systemic therapies until …

… thyroid carcinoma is an aggressive cancer subtype with a dismal prognosis. Multimodal
treatment approaches consisting of surgical resection, radiation therapy (RT… a systematic review …